Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 江西富祥药业股份有限公司是一家专业从事化学药物研发、生产、销售和服务的创新型制药企业，下设江西祥太制药有限公司等3家全资子公司，是国家高新技术企业、江西省优秀企业、江西省优秀非公有制企业、江西省创新型试点企业，并设有"省级企业技术中心"。公司拥有核心技术和较强的研发创新能力，拥有多项国家发明专利以及十多个省级重点新产品、优秀科技新产品，部分产品已纳入江西省科技创新"六个一"工程和江西省十大战略性新兴产业"生物和新医药"研发引导计划，是江西省化学合成药发展规划中的龙头骨干企业。公司拥有较强的市场开拓能力，是目前全球最大的β-内酰胺酶抑制剂原料药生产基地，也是碳青霉烯类药物及其中间体的主要供应商之一。
Main Business 抗感染药物原料药、中间体的研发、生产和销售，以及锂电池电解液添加剂业务
Legal Representative 包建华
Top Executives
董事长：包建华
副董事长：李惠跃
董事：程荣武,李惠跃,柯丹
独立董事：陈祥强,刘洪,计小青
Top 5 Shareholder
Shareholder name Nature Holding Date
包建华限售股+流通A股19.71%30/09/2024
喻文军限售股+流通A股3.20%30/09/2024
青岛恒泽睿基金管理有限公司－恒泽睿精选二期私募证券投资基金流通A股1.54%30/09/2024
景德镇市富祥投资有限公司流通A股1.37%30/09/2024
景德镇国控金融发展有限公司流通A股1.22%30/09/2024
Company Secretary 彭云
Solicitors 北京卓纬律师事务所
Auditors 立信会计师事务所（特殊普通合伙）
Tel No 0798-2699929
Fax No 0798-2699928
Website www.fushine.cn
Email stock@fushine.cn
Company Address
Register: 江西省景德镇市昌江区鱼丽工业区2号（鱼山与丽阳交界处）
Office: 江西省景德镇市昌江区鱼丽工业区2号（鱼山与丽阳交界处）
Listing Date 22/12/2015
Shares Capital
Shares Capital: 550,004,834
Total A Share: 550,004,834
Listed A Share: 451,620,728
Non-tradable A Share: 98,384,106
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ -0.370
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 4.518
Market Capitalization(RMB) 4.083B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.